183 related articles for article (PubMed ID: 11364991)
1. Combination study for children.
Vazquez E
Posit Aware; 1998; 9(1):15. PubMed ID: 11364991
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
Starr SE; Fletcher CV; Spector SA; Yong FH; Fenton T; Brundage RC; Manion D; Ruiz N; Gersten M; Becker M; McNamara J; Mofenson LM; Purdue L; Siminski S; Graham B; Kornhauser DM; Fiske W; Vincent C; Lischner HW; Dankner WM; Flynn PM
N Engl J Med; 1999 Dec; 341(25):1874-81. PubMed ID: 10601506
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
4. Preparing for the future.
Cox S
Posit Aware; 1997; 8(2):10-1. PubMed ID: 11364448
[TBL] [Abstract][Full Text] [Related]
5. Update on antivirals.
Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy for previously treated patients.
Montaner JS; Mellors JW
N Engl J Med; 2001 Aug; 345(6):452-5. PubMed ID: 11496858
[No Abstract] [Full Text] [Related]
7. Choosing the best initial therapy for HIV-1 infection.
Clumeck N
N Engl J Med; 1999 Dec; 341(25):1925-6. PubMed ID: 10601514
[No Abstract] [Full Text] [Related]
8. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Albrecht MA; Bosch RJ; Hammer SM; Liou SH; Kessler H; Para MF; Eron J; Valdez H; Dehlinger M; Katzenstein DA;
N Engl J Med; 2001 Aug; 345(6):398-407. PubMed ID: 11496850
[TBL] [Abstract][Full Text] [Related]
9. DMP 266 and indinavir combination.
AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
[No Abstract] [Full Text] [Related]
10. Women's nelfinavir (Viracept) trial.
Vazquez E
Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
[TBL] [Abstract][Full Text] [Related]
11. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
12. CRIA clinical trials.
Newsline People AIDS Coalit N Y; 1998 Sep; ():59. PubMed ID: 11367496
[TBL] [Abstract][Full Text] [Related]
13. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
14. Dupont data supports earlier findings.
Slovick J
Posit Living; 1999 Nov; 8(10):45. PubMed ID: 11367331
[TBL] [Abstract][Full Text] [Related]
15. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
16. [Use of antiretroviral drugs in HIV infected children in a tropical area: a real benefit].
Timité-Konan AM; Fassinou P; Adonis-Koffy L; N'dja BB
Arch Pediatr; 2003 Sep; 10(9):831-2. PubMed ID: 12972212
[No Abstract] [Full Text] [Related]
17. Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children.
Spector SA; Hsia K; Yong FH; Cabral S; Fenton T; Fletcher CV; McNamara J; Mofenson LM; Starr SE
J Infect Dis; 2000 Dec; 182(6):1769-73. PubMed ID: 11069252
[TBL] [Abstract][Full Text] [Related]
18. DMP 266 on the horizon.
Vazquez E
Posit Aware; 1997; 8(5):25. PubMed ID: 11364636
[TBL] [Abstract][Full Text] [Related]
19. DuPont initiates Sustiva oral liquid expanded access program.
AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881361
[No Abstract] [Full Text] [Related]
20. High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease.
Maserati R; Villani P; Seminari E; Pan A; Lo Caputo S; Regazzi MB
AIDS; 1999 May; 13(7):870-1. PubMed ID: 10357395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
